Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Hepatocellular carcinoma, Cell growth, Decoction, PI3K/AKT/mTOR pathway, and Protein kinase B.
Prediction of the effect of Bupleurum chinensis DC. (Chaihu) on survival and its potential targets in hepatocellular carcinoma based on a prognostic model
Clinical Efficacy of Hexue Tongbi Formula on Oxaliplatin-Induced Peripheral Neuropathy: A Randomized Controlled Study
Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction suppresses cell proliferation and induced cell apoptisis in hepatocellular carcinoma via PI3K/Akt/P53/FoxO signaling axis
Hsa_circ_0048674 facilitates hepatocellular carcinoma progression and natural killer cell exhaustion depending on the regulation of miR-223-3p/PDL1.
Research Trend of Publications Concerning Antibody-Drug Conjugate in Solid Cancer: A Bibliometric Study
Efficacy of sintilimab and fruquintinib combination treatment in the management of microsatellite-stable metastatic colorectal cancer: a case report
Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction Suppresses Cell Proliferation and Induced Cell Apoptisis in Hepatocellular Carcinoma via PI3K/Akt/P53/FoxO Signaling Axis
Additional file 2 of Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction suppresses cell proliferation and induced cell apoptisis in hepatocellular carcinoma via PI3K/Akt/P53/FoxO signaling axis
Additional file 3 of Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction suppresses cell proliferation and induced cell apoptisis in hepatocellular carcinoma via PI3K/Akt/P53/FoxO signaling axis
A Data Mining-Based Analysis of Core Herbs on Different Patterns (Zheng) of Non-Small Cell Lung Cancer
Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature
Yiqi Chutan Tang Reduces Gefitinib‐Induced Drug Resistance in Non‐Small‐Cell Lung Cancer by Targeting Apoptosis and Autophagy
Cp*Co(<scp>iii</scp>)-Catalyzed oxidative [5+2] annulation: regioselective synthesis of 2-aminobenzoxepines <i>via</i> C–H/O–H functionalization of 2-vinylphenols with ynamides